- Home
- TAK vs BKR Comparison
TAK vs BKR Comparison
Compare TAK & BKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- BKR
- Stock Information
- Founded
- TAK 1781
- BKR 2016
- Country
- TAK Japan
- BKR United States
- Employees
- TAK N/A
- BKR N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- BKR Metal Fabrications
- Sector
- TAK Health Care
- BKR Industrials
- Exchange
- TAK Nasdaq
- BKR Nasdaq
- Market Cap
- TAK 42.2B
- BKR 40.5B
- IPO Year
- TAK N/A
- BKR N/A
- Fundamental
- Price
- TAK $14.71
- BKR $38.91
- Analyst Decision
- TAK
- BKR Strong Buy
- Analyst Count
- TAK 0
- BKR 20
- Target Price
- TAK N/A
- BKR $49.89
- AVG Volume (30 Days)
- TAK 2.5M
- BKR 10.0M
- Earning Date
- TAK 05-08-2025
- BKR 04-22-2025
- Dividend Yield
- TAK 4.01%
- BKR 2.41%
- EPS Growth
- TAK 15.39
- BKR 56.02
- EPS
- TAK 0.83
- BKR 2.98
- Revenue
- TAK $29,124,927,177.00
- BKR $27,829,000,000.00
- Revenue This Year
- TAK $8.53
- BKR $0.68
- Revenue Next Year
- TAK N/A
- BKR $3.77
- P/E Ratio
- TAK $34.69
- BKR $13.06
- Revenue Growth
- TAK 9.83
- BKR 9.11
- 52 Week Low
- TAK $12.58
- BKR $30.93
- 52 Week High
- TAK $15.37
- BKR $49.40
- Technical
- Relative Strength Index (RSI)
- TAK 52.69
- BKR 44.44
- Support Level
- TAK $13.60
- BKR $34.07
- Resistance Level
- TAK $15.37
- BKR $38.55
- Average True Range (ATR)
- TAK 0.33
- BKR 2.13
- MACD
- TAK -0.03
- BKR -0.06
- Stochastic Oscillator
- TAK 62.71
- BKR 46.58
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About BKR Baker Hughes Company
Following a 2022 reorganization, Baker Hughes operates across two segments: oilfield services and equipment, and industrial and energy technology. The firm's oilfield services and equipment segment, or OFSE, is one of the Big Three oilfield service players, along with SLB and Halliburton, and mostly supplies to hydrocarbon developers and producers, including national oil companies, major integrated firms, and independents. Markets outside of North America buy roughly three quarters of the firm's OFSE. Baker Hughes' industrial and energy technology segment manufactures and sells turbines, compressors, pumps, valves, and related testing and monitoring services across various energy and industrial applications.